Nicholas S Goeden

Title: Innovations in Gene Therapy by Nicholas S. Goeden

Introduction

Nicholas S. Goeden is a prominent inventor based in Thousand Oaks, CA (US). He has made significant contributions to the field of gene therapy, particularly through his work with adeno-associated viruses. With a total of 2 patents, his innovations are paving the way for more effective treatments in targeted gene therapy.

Latest Patents

Goeden's latest patents focus on adeno-associated virus compositions designed for targeted gene therapy. These patents describe compositions and kits that comprise recombinant adeno-associated viruses (rAAVs) with tropisms that show increased specificity and efficiency of viral transduction in targeted cell types, such as the brain and lung. The rAAV compositions encapsidate a transgene, such as a therapeutic nucleic acid, which, upon systemic delivery to a subject, can achieve increased specificity and transduction of the transgene in target cell types compared to parental or reference AAVs.

Career Highlights

Nicholas S. Goeden is affiliated with the California Institute of Technology, where he continues to advance research in gene therapy. His work is characterized by a commitment to improving the specificity and efficiency of viral transduction, which is crucial for the success of gene therapies.

Collaborations

Goeden has collaborated with notable colleagues, including Viviana Gradinaru and Nicholas C. Flytzanis. These collaborations enhance the research environment and contribute to the innovative work being done in the field of gene therapy.

Conclusion

Nicholas S. Goeden's contributions to gene therapy through his innovative patents and collaborations are making a significant impact in the medical field. His work exemplifies the potential of targeted gene therapy to transform treatment options for various diseases.